Changes in Beneficial Ownership · 4
DSS, Inc.
DSSNYSE_AMERICANEQUITYCurrent
Changes in Beneficial Ownership
Structured filing — 4
ownership.xml
Filing details
- Report period
- 2026-06-03
- Issuer
- DSS, INC.
- Issuer CIK
- 0000771999
- Trading symbol
- DSS
Reporting owner 1
- Name
- Chan Heng Fai Ambrose
- Reporting owner CIK
- 0001261725
- Relationship
- Director · 10% owner
- Address
- 9 TEMASEK BOULEVARD, #16-04 SUNTEC TOWER TWO, SINGAPORE, SINGAPORE, U0, 038989
Reporting owner 2
- Name
- Alset Inc.
- Reporting owner CIK
- 0001750106
- Relationship
- 10% owner
- Address
- 4800 MONTGOMERY LANE, SUITE 210, BETHESDA, MD, 20814
Reporting owner 3
- Name
- Alset International Ltd
- Reporting owner CIK
- 0001660984
- Relationship
- 10% owner
- Address
- 9 TEMASEK BOULEVARD, #16-04 SUNTEC TOWER TWO, SINGAPORE, SINGAPORE, U0, 038989
Derivative transactions
| Security | Conversion / exercise price (USD) | Transaction date | Code | Amount | A / D | Price (USD) | Exercisable | Expires | Underlying security | Underlying shares | Owned after | Value owned (USD) | Ownership | Nature of ownership |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Convertible Promissory Note[F1] | [F1] | 2026-06-03 | J · Form 4 | A | 0.74[F1] | 2026-06-03 | 2031-03-26 | Common Stock | [F1] | 2,450,000[F3][F4] | I | See footnote[F3][F4] | ||
| Common Stock Purchase Warrant | [F2] | 2026-06-03 | J · Form 4 | 16,554,055[F2] | A | 0.93[F2] | 2026-06-03 | 2031-03-26 | Common Stock | 16,554,055[F2] | 16,554,055[F3][F4] | I | See footnote[F3][F4] |
Table key
- J · Form 4
- Other acquisition or disposition; see explanation
- A
- Acquired
- I
- Indirect
Footnotes
- F1
- On March 26, 2026 the Issuer issued a convertible promissory note (the "Convertible Promissory Note") to Alset International Limited in the amount of $2,450,000, which became convertible on June 3, 2026. Under the terms of the Convertible Promissory Note, Alset International Limited may convert outstanding principal and interest into shares of the Issuer's common stock at a conversion price of either (i) $0.74 per share, or (ii) if while the Convertible Promissory Note is outstanding, the Issuer sells or issues any other convertible instruments on terms that differ from the Convertible Promissory Note, the Holder may elect to exchange the Convertible Promissory Note for such convertible instrument based on the Convertible Promissory Note's principal balance plus any accrued but unpaid interest.↩ 1↩ 2↩ 3↩ 4
- F2
- On March 26, 2026 the Issuer issued common stock purchase warrants (the "Warrants") to Alset International Limited to purchase up to 16,554,055 shares of the Issuer's common stock at an exercise price of $0.93 per share. The Warrants expire on March 26, 2031.↩ 1↩ 2↩ 3↩ 4
- F3
- The beneficial ownership of Mr. Chan as of the date hereof may be deemed to include the following shares held personally (a) 1,002,978 shares of the Issuer's common stock held by Heng Fai Holdings Limited, an entity controlled by Heng Fai Chan; (b) 1,184,475 shares of the Issuer's common stock held by Mr. Chan directly.↩ 1↩ 2↩ 3↩ 4
- F4
- Mr. Chan may also be deemed to beneficially own (a) 2,581,268 shares of the Issuer's common stock held by Alset Inc., an entity controlled by Mr. Chan; (b) a convertible promissory note in the amount of $500,000 held by Alset Inc. and convertible into shares of the Issuer's common stock; (c) 1,068,309 shares of the Issuer's common stock, a convertible promissory note in the amount of $2,450,000, and common stock purchase warrants to purchase up to 16,554,055 shares held by Alset International Limited, an entity controlled by Mr. Chan and a subsidiary of Alset Inc.; and (d) 311,634 shares of the Issuer's common stock held by Global Biomedical Pte. Ltd., an entity controlled by Mr. Chan and a subsidiary of Alset International Limited (which is a subsidiary of Alset Inc.).↩ 1↩ 2↩ 3↩ 4
Signature 1
- Signed
- /s/ Heng Fai Ambrose Chan
- Date
- 2026-07-09
Signature 2
- Signed
- Alset Inc. /s/ Heng Fai Ambrose Chan, Chief Executive Officer
- Date
- 2026-07-09
Signature 3
- Signed
- Alset International Limited /s/ Heng Fai Ambrose Chan, Chief Executive Officer
- Date
- 2026-07-09
Company context
DSS, Inc. (together with its consolidated subsidiaries, referred to herein as “DSS,” “we,” “us,” “our,” or the “Company”) is a multi-segment operating company focused on packaging, biotechnology, financial services, and investment platform businesses. The Company operates through four principal business segments: Product Packaging, Biotechnology, Commercial Lending, and Securities and Investment Management. Through these segments, the Company seeks to develop and operate businesses across industries where management believes opportunities exist to create long-term shareholder value through operational growth, strategic partnerships, and the development or acquisition of complementary business platforms.